Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Radiosurgery × CNS × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 113 Neoplasm Metastasis 29 Glioblastoma 22 Melanoma 21 Breast Neoplasms 14 Lung Neoplasms 13 Carcinoma, Non-Small-Cell Lung 12 Glioma 11 Neoplasms 8 Gliosarcoma 7 Central Nervous System Neoplasms 7 Small Cell Lung Carcinoma 6 Neuroma, Acoustic 6 Meningioma 6 Carcinoma, Renal Cell 6 Spinal Cord Neoplasms 4 Recurrence 4 Astrocytoma 4 Sarcoma 3 Gastrointestinal Neoplasms 3 Uveal Melanoma 2 Radiation Injuries 2 Prostatic Neoplasms 2 Oligodendroglioma 2 Kidney Neoplasms 2 Fatigue 2 Depression 2 Colorectal Neoplasms 2 Breast Neoplasms, Male 2 Anxiety Disorders 2

Interventions

Patient Reported Outcome Measures 2 Neuropsychological Tests 2 lithium sulfate 1 XENP 1595 1 Sodium Chloride 1 Ramipril 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Quality of Life 1 Pioglitazone 1 Mental Status and Dementia Tests 1 Memantine 1 Lithium 1 G(M1) Ganglioside 1 Donepezil 1 Climate Anxiety 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06466720 2024-12-11

CoDeB-Rad

University of Nottingham

Brain Neoplasms, Meningioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡